Neuronetics, Inc. Provides Earning Guidance for the Second Quarter and Full Year of 2022
For the second quarter of 2022, the Company expects to report total worldwide revenue of between $15.0 million and $16.0 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.893 USD | -7.21% | -17.70% | -34.72% |
05-15 | Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents | CI |
05-14 | William Blair Upgrades Neuronetics to Outperform From Market Perform | MT |
1st Jan change | Capi. | |
---|---|---|
-34.72% | 61.2M | |
+6.02% | 217B | |
+9.25% | 190B | |
+19.58% | 141B | |
+29.74% | 110B | |
+1.63% | 64.8B | |
+15.27% | 52.44B | |
+2.69% | 49.94B | |
-5.47% | 42.63B | |
+1.58% | 35.81B |